Peter Bytzer

Peter Bytzer

Deputy head of department, Professor, emeritus, Professor Emeritus

Member of:

  • Internal Medicine: Gastroenterology and Hepatology


  1. 2017
  2. Published

    Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome-getting the facts right. Authors' reply

    Krogsgaard, L. R., Lyngesen, M. & Bytzer, Peter, 2017, In: Alimentary Pharmacology and Therapeutics. 46, 3, p. 386-387

    Research output: Contribution to journalComment/debateResearch

  3. Published

    Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication

    Semb, S., Helgstrand, Frederik, Hjørne, F. & Bytzer, Peter, 2017, In: World Journal of Gastroenterology. 23, 37, p. 6907-6910

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Psychometric evaluation of a daily gastro-oesophageal reflux disease symptom measure

    Bytzer, Peter, Reimer, C., Smith, G., Anatchkova, M. D., Hsieh, R., Wilkinson, J., Thomas, S. J. & Lenderking, W. R., 2017, In: Scandinavian Journal of Gastroenterology. 52, 3, p. 276-283 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms

    Coyle, C., Crawford, G., Wilkinson, J., Thomas, S. J. & Bytzer, Peter, 2017, In: Alimentary Pharmacology and Therapeutics. 45, 12, p. 1524-1533

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome

    Krogsgaard, L. R., Lyngesen, M. & Bytzer, Peter, 2017, In: Alimentary Pharmacology and Therapeutics. 45, 12, p. 1506-1513

    Research output: Contribution to journalReviewResearchpeer-review

  7. 2016
  8. Published

    Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota

    Elison, E., Vigsnæs, L. K., Krogsgaard, L. R., Rasmussen, J., Sørensen, N., McConnell, B., Hennet, T., Sommer, M. O. A. & Bytzer, Peter, Oct 2016, In: Nutrition Research Reviews. 116, 8, p. 1356-1368 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Letter: add-on alginate therapy for refluxpatients with inadequate response to aonce daily proton pump inhibitor – morequestions than answers. Authors’ reply

    Bytzer, Peter & Reimer, C., Jul 2016, In: Alimentary Pharmacology and Therapeutics. 44, 2, p. 208 1 p.

    Research output: Contribution to journalComment/debateResearch

  10. Published

    Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor

    Reimer, C., Lødrup, A., Smith, G., Wilkinson, J. & Bytzer, Peter, Apr 2016, In: Alimentary Pharmacology and Therapeutics. 43, 8, p. 899-909

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. 2015
  12. Published

    PMD34 A Novel Ibs Diagnostic Blood Panel Can Enhance A Positive Diagnostic Strategy Versus A Strategy Of Exclusion For Patients With Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D): Cost Implications For Denmark

    Purdy, C., Bytzer, Peter, Pimentel, M. M. & Magar, R., Nov 2015, In: Value in Health. 18, 7, p. A350

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  13. Published

    Editorial: anti-secretory therapy prior to anti-reflux surgery. Does dose matter? Authors' reply

    Lødrup, A., Pottegård, A., Hallas, J. & Bytzer, Peter, Sep 2015, In: Alimentary Pharmacology and Therapeutics. 42, 5, p. 627-627 1 p.

    Research output: Contribution to journalEditorialResearchpeer-review

ID: 547129